Answers are grounded in this paper and cite their sources.
Menopause is a natural biological transition characterised by declining oestrogen levels, with significant effects on skin structure, barrier function, and inflammation. While these physiological changes are well recognised, the impact of menopause on common inflammatory dermatoses remains poorly understood. This review examines the current evidence on acne, rosacea, hidradenitis suppurativa, psoriasis, lichen sclerosus, and lichen planus in peri- and postmenopausal women, focusing on clinical presentation and management. The relationship between menopause and individual inflammatory dermatoses is complex, with considerable variation in disease presentation and response to hormonal treatment. In particular, the role of hormone replacement therapy remains uncertain. Management should therefore continue to follow established disease-specific guidelines, while taking into account menopausal symptoms, hormonal treatments, skin sensitivity and associated comorbidities. Further prospective studies incorporating hormonal measurements, molecular markers, and treatment responses are needed to better understand the relationship between menopause and inflammatory skin disease and develop evidence-based management strategies for women during and after the menopausal transition.
No takes yet. Share an insight, caveat, or question.
Pharveen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: